Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.95 is in line with its 5-year average of -0.97, around the middle of its 5-year range (-1.99–-0.44).
68.14% below its 12-month average of -0.56.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.14.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 22 comparable quarters.
EARNINGS PER SHARE (EPS)
-0.95
EARNINGS PER SHARE (EPS) AVG TTM
-0.56
EARNINGS PER SHARE (EPS) AVG 3Y
-0.99
EARNINGS PER SHARE (EPS) AVG 5Y
-0.97
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-68.14%
CURRENT VS 3Y AVG
+3.80%
CURRENT VS 5Y AVG
+2.23%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Erasca, Inc.
Market Cap
$4.98B
Earnings Per Share (EPS)
-0.95
TTM Avg
-0.56
3Y Avg
-0.99
5Y Avg
-0.97
Market Cap
$4.85B
Earnings Per Share (EPS)
-14.56
TTM Avg
-1.16
3Y Avg
-2.58
5Y Avg
-2.86
Market Cap
$5.06B
Earnings Per Share (EPS)
-3.31
TTM Avg
-2.88
3Y Avg
-2.49
5Y Avg
-2.72
Market Cap
$5.06B
Earnings Per Share (EPS)
2.42
TTM Avg
2.12
3Y Avg
1.80
5Y Avg
1.31
Market Cap
$4.74B
Earnings Per Share (EPS)
-2.47
TTM Avg
-3.65
3Y Avg
-5.00
5Y Avg
-7.51
Market Cap
$4.77B
Earnings Per Share (EPS)
-0.13
TTM Avg
-3.38
3Y Avg
-5.70
5Y Avg
-8.99
Market Cap
$4.69B
Earnings Per Share (EPS)
0.62
TTM Avg
-0.43
3Y Avg
-0.91
5Y Avg
-0.91
Market Cap
$5.20B
Earnings Per Share (EPS)
-2.31
TTM Avg
-2.18
3Y Avg
-2.26
5Y Avg
-2.81
Market Cap
$4.65B
Earnings Per Share (EPS)
1.33
TTM Avg
1.25
3Y Avg
1.21
5Y Avg
0.93
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Erasca, Inc. (ERAS) | $4.98B | -0.95 | -0.56 | -0.99 | -0.97 |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.85B | -14.56 | -1.16 | -2.58 | -2.86 |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.06B | -3.31 | -2.88 | -2.49 | -2.72 |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.06B | 2.42 | 2.12 | 1.80 | 1.31 |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.74B | -2.47 | -3.65 | -5.00 | -7.51 |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.77B | -0.13 | -3.38 | -5.70 | -8.99 |
| BillionToOne, Inc. (BLLN)vs › | $4.69B | 0.62 | -0.43 | -0.91 | -0.91 |
| Cogent Biosciences, Inc. (COGT)vs › | $5.20B | -2.31 | -2.18 | -2.26 | -2.81 |
| Option Care Health, Inc. (OPCH)vs › | $4.65B | 1.33 | 1.25 | 1.21 | 0.93 |
| LifeStance Health Group, Inc. (LFST)vs › | $4.65B | 0.13 | -0.06 | -0.31 | -0.46 |
Trailing EPS (TTM)
$-0.95
Forward EPS (Est.)
$-0.97
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.44 |
| 2024-12-31 | -0.69 |
| 2023-12-31 | -0.83 |
| 2022-12-31 | -1.99 |
| 2021-12-31 | -1.03 |
| 2020-12-31 | -0.85 |
| 2019-12-31 | -0.10 |
